Happy Friday!
A tropical storm system will be traveling up through the mid-Atlantic this weekend, bringing wind and rain. Hunker down!
This week, we have stories on Duke University being recognized as a dystonia Center of Excellence, the ongoing need for diverse blood donors for sickle cell disease, and a new potential therapeutic target for glioblastoma, a deadly brain cancer.
Duke Earns Recognition as Dystonia Center of Excellence
Duke University has been recognized as a Dystonia Center of Excellence from a nonprofit organization.
More Diverse Blood Donors are Needed to Support Patients with Sickle Cell Disease
Blood donors from diverse backgrounds are desperately needed to help support people living with sickle cell disease, a rare illness.
Did Researchers Identify New Therapeutic Targets for Glioblastoma?
The latest research may have identified a new treatment target for glioblastoma, a deadly and rare brain cancer.
